Non-clinical Safety and Efficacy of an AAV2/8 Vector Administered Intravenously for Treatment of Mucopolysaccharidosis Type VI.
about
Non-clinical Safety and Efficacy of an AAV2/8 Vector Administered Intravenously for Treatment of Mucopolysaccharidosis Type VI.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Non-clinical Safety and Effica ...... Mucopolysaccharidosis Type VI.
@en
type
label
Non-clinical Safety and Effica ...... Mucopolysaccharidosis Type VI.
@en
prefLabel
Non-clinical Safety and Effica ...... Mucopolysaccharidosis Type VI.
@en
P2093
P2860
P1476
Non-clinical Safety and Effica ...... Mucopolysaccharidosis Type VI.
@en
P2093
Alberto Auricchio
Edoardo Nusco
Jean-Brice Marteau
Margherita Dell'Anno
Maria Grazia Valsecchi
Marialuisa Alliegro
Rita Ferla
Severine Pouillot
Stefania Galimberti
Vincent Zuliani
P2860
P304
P356
10.1016/J.OMTM.2017.07.004
P577
2017-07-24T00:00:00Z